These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 15350333)

  • 41. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful treatment with 5-Fu.
    Schechter BA; Nagler RS
    Ophthalmology; 2003 Jun; 110(6):1262-3; author reply 1263. PubMed ID: 12799258
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
    Haas K; Ben-Dor D; Levartovsky S
    Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
    [No Abstract]   [Full Text] [Related]  

  • 46. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
    Nemet AY; Sharma V; Benger R
    Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of biopsy proved conjunctival intraepithelial neoplasia with topical interferon alfa-2b.
    Esquenazi S; Fry CL; Holley E
    Br J Ophthalmol; 2005 Sep; 89(9):1221. PubMed ID: 16113387
    [No Abstract]   [Full Text] [Related]  

  • 48. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor-volume increase at beginning of primary treatment with topical interferon alpha 2-beta in a case of conjunctiva-cornea intraepithelial neoplasia.
    Huerva V; Sánchez MC; Mangues I
    J Ocul Pharmacol Ther; 2007 Apr; 23(2):143-5. PubMed ID: 17444802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical interferon alpha-2B topic as the first therapeutic option in a clinical case of conjunctival intraepithelial neoplasia.
    Pagán Carrasco S; Arranz Maestro D
    Arch Soc Esp Oftalmol; 2017 Sep; 92(9):442-446. PubMed ID: 28292536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of conjunctival papillomata with topical interferon Alfa-2b.
    Schechter BA; Rand WJ; Velazquez GE; Williams WD; Starasoler L
    Am J Ophthalmol; 2002 Aug; 134(2):268-70. PubMed ID: 12140037
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
    Rodríguez-Pérez C; Del Campo Z; Wolley-Dod C; Gris O
    Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and safety of topical 5-fluorouracil in conjunctival intraepithelial neoplasia refractory to interferon alpha-2b.
    Pérez-García P; Burgos-Blasco B; Gómez-Calleja V; Vidal-Villegas B; Méndez-Fernández R; Gegúndez-Fernández JA; Díaz-Valle D
    J Oncol Pharm Pract; 2023 Jun; 29(4):975-979. PubMed ID: 36131486
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
    Venkateswaran N; Mercado C; Galor A; Karp CL
    Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment with topical interferon alone in severe conjunctivo-corneal neoplasia].
    Díaz-Valle D; Benítez-del-Castillo JM; Díaz-Valle T; Poza-Morales Y; Arteaga-Sánchez A
    Arch Soc Esp Oftalmol; 2005 Dec; 80(12):729-32. PubMed ID: 16372217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Adjuvant topical interferon-alpha-2b treatment in epithelial tumors of the ocular surface].
    Fuchsluger TA; Hintschich C; Steuhl KP; Meller D
    Ophthalmologe; 2006 Feb; 103(2):124-8. PubMed ID: 16047150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of intraepithelial and invasive neoplasia of the cornea and conjunctiva: a long-term follow up.
    Zaki AA; Farid SF
    Cornea; 2009 Oct; 28(9):986-8. PubMed ID: 19724215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conjunctival intraepithelial neoplasia. Interferon as a rescue therapy after failure of mitomycin C.
    de la Cruz Aguiló RI; Duch-Samper A; Hernández Pérez D; Marí Cotino J
    Arch Soc Esp Oftalmol; 2014 Nov; 89(11):463-5. PubMed ID: 24377953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification.
    Shields CL; Kaliki S; Kim HJ; Al-Dahmash S; Shah SU; Lally SE; Shields JA
    Cornea; 2013 Mar; 32(3):248-56. PubMed ID: 22580436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.